
Candida auris represents an urgent health threat. Here, we identified atazanavir as a potent drug capable of resensitizing C. auris clinical isolates to the activity of azole antifungals.
Azoles, Antifungal Agents, HIV protease inhibitors, efflux pumps, Atazanavir Sulfate, Microbial Sensitivity Tests, Candida auris, Mice, azole resistance, Drug Resistance, Fungal, Animals, in vivo disseminated candidiasis mouse model, Itraconazole, Fluconazole, atazanavir, Candida
Azoles, Antifungal Agents, HIV protease inhibitors, efflux pumps, Atazanavir Sulfate, Microbial Sensitivity Tests, Candida auris, Mice, azole resistance, Drug Resistance, Fungal, Animals, in vivo disseminated candidiasis mouse model, Itraconazole, Fluconazole, atazanavir, Candida
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 13 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
